UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$25.3B |
| 2 |
Bank of America
BAC
|
+$1.96B |
| 3 |
Applied Materials
AMAT
|
+$1.43B |
| 4 |
NetEase
NTES
|
+$1.18B |
| 5 |
Union Pacific
UNP
|
+$870M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$7.17B |
| 2 |
Apple
AAPL
|
+$3.39B |
| 3 |
UBS Group
UBS
|
+$2.73B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$2.53B |
| 5 |
Meta Platforms (Facebook)
META
|
+$2.04B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 37.88% |
| 2 | Financials | 12.37% |
| 3 | Consumer Discretionary | 10.53% |
| 4 | Healthcare | 9.66% |
| 5 | Communication Services | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Establishment Labs
ESTA
$2.22B
| $2.09M | ﹤0.01% |
51,103
-30,806
| -38% | -$1.26M |
|
1727
TFS Financial
TFSL
$4.86B
| $2.09M | ﹤0.01% |
158,970
-76,443
| -32% | -$1.01M |
|
1728
Cannae Holdings
CNNE
$651M
| $2.09M | ﹤0.01% |
113,895
-78,644
| -41% | -$1.55M |
|
1729
Bank First Corp
BFC
$1.72B
| $2.08M | ﹤0.01% |
17,142
-10,718
| -38% | -$1.33M |
|
1730
BrightView Holdings
BV
$1.05B
| $2.08M | ﹤0.01% |
155,039
-80,745
| -34% | -$1.2M |
|
1731
CTS Corp
CTS
$1.83B
| $2.08M | ﹤0.01% |
52,016
-49,105
| -49% | -$2.04M |
|
1732
United States Lime & Minerals
USLM
$3.42B
| $2.07M | ﹤0.01% |
15,703
-12,742
| -45% | -$1.47M |
|
1733
Syndax Pharmaceuticals
SNDX
$1.8B
| $2.07M | ﹤0.01% |
134,261
-121,877
| -48% | -$1.6M |
|
1734
Ducommun
DCO
$2.97B
| $2.06M | ﹤0.01% |
21,456
-24,618
| -53% | -$2.22M |
|
1735
Phibro Animal Health
PAHC
$1.39B
| $2.06M | ﹤0.01% |
50,923
-39,734
| -44% | -$1.31M |
|
1736
Apogee Enterprises
APOG
$902M
| $2.06M | ﹤0.01% |
47,166
-28,554
| -38% | -$1.23M |
|
1737
Cogent Biosciences
COGT
$6.63B
| $2.05M | ﹤0.01% |
142,954
-64,244
| -31% | -$761K |
|
|
VMEO
1738
DELISTED
Vimeo
VMEO
| $2.05M | ﹤0.01% |
264,847
-227,329
| -46% | -$1.12M |
|
1739
CareDx
CDNA
$2.47B
| $2.05M | ﹤0.01% |
140,919
-133,769
| -49% | -$1.91M |
|
1740
BioLife Solutions
BLFS
$1.71B
| $2.05M | ﹤0.01% |
80,254
-11,608
| -13% | -$275K |
|
1741
NETGEAR
NTGR
$646M
| $2.04M | ﹤0.01% |
63,085
-41,314
| -40% | -$1.13M |
|
1742
Virtus Investment Partners
VRTS
$1.12B
| $2.04M | ﹤0.01% |
10,737
-9,690
| -47% | -$1.91M |
|
1743
Ardelyx
ARDX
$982M
| $2.04M | ﹤0.01% |
370,109
-264,136
| -42% | -$1.43M |
|
1744
Clover Health Investments
CLOV
$2.34B
| $2.03M | ﹤0.01% |
664,630
-437,179
| -40% | -$1.25M |
|
1745
Simon Property Group
SPG
$71.6B
| $2.03M | ﹤0.01% |
10,824
-429,671
| -98% | -$74.2M |
|
1746
Under Armour
UAA
$2.31B
| $2.03M | ﹤0.01% |
406,399
-243,683
| -37% | -$1.42M |
|
1747
1st Source
SRCE
$2.12B
| $2.02M | ﹤0.01% |
32,859
-25,143
| -43% | -$1.58M |
|
1748
Monarch Casino & Resort
MCRI
$2.21B
| $2M | ﹤0.01% |
18,905
-18,270
| -49% | -$1.83M |
|
1749
Collegium Pharmaceutical
COLL
$852M
| $1.99M | ﹤0.01% |
57,016
-37,771
| -40% | -$1.31M |
|
1750
Crescent Energy
CRGY
$4.11B
| $1.99M | ﹤0.01% |
223,296
-237,779
| -52% | -$2.16M |
|
Similar funds
UBS AM's Q3 2025 Portfolio in Review
As of Q3 2025, UBS AM held 2,672 positions worth $461B, down 6.8% from $494B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
UBS AM withdrew a net $68.7B in Q3 2025, closing 403 positions and reducing 2,008 holdings. Its most notable exit was Pinduoduo, an estimated $967M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, UBS AM opened a new position in Vanguard Dividend Appreciation ETF worth $135M.
- UBS AM's largest Q3 2025 buy was Vanguard Dividend Appreciation ETF: 624,303 shares worth $135M.
- UBS AM added most to Microsoft in Q3 2025, an estimated $25.3B increase.
- UBS AM's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $7.17B.
- UBS AM fully exited Pinduoduo in Q3 2025, selling an estimated $967M.
- UBS AM's ten largest holdings make up 35% of its $461B portfolio in Q3 2025.
- UBS AM opened 67 new positions and closed 403 in Q3 2025.
- UBS AM's portfolio value fell 6.8% quarter-over-quarter to $461B.
Based on UBS AM's 13F filing for Q3 2025, filed 14 Nov 2025.